Clinical Trial Update: AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH [Phase 3]

View source ↗

Summary

Phase 3 trial comparing AC-CHOP to CHOP in previously untreated PTCL-TFH is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Peripheral T-cell Lymphoma Targeted Therapy | Phase 3 | Status: ENROLLING_BY_INVITATION